The scope of this review is to correlate the impact of PTX3 in DM and progression of complications, as well as antidiabetic drugs’ influence, considering that inflammatory pathways are pillars in the evolution of this metabolic disease. This evidence concerns the gene PTX3 and metabolic disease.